Intrinsic Value of S&P & Nasdaq Contact Us

GSK plc GSK NYSE

NYSE • Healthcare • Drug Manufacturers - General • GB • USD

SharesGrow Score
64/100
4/7 Pass
SharesGrow Intrinsic Value
$145.21
+145.4%
Analyst Price Target
$53.00
-10.4%

Stock Statistics — GSK

GSK plc (GSK) has a market capitalization of $118.67B and trades at $59.18. The 52-week range is 32.38-61.7.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 21.4, Earnings Per Share (EPS) of $2.76, annual revenue of $31.95B.

The stock has a beta of 0.35, a last dividend of $1.7609, operates in the Healthcare sector.

Trading Data
Current Price$59.18
52-Week Range32.38-61.7
Volume3.74M
Avg Volume (30D)5.56M
Market Cap$118.67B
Beta (1Y)0.35
Last Dividend$1.7609
Company
IPO Date1980-03-28
Employees68,629
CEOLuke Victor Miels
CountryGB
ExchangeNYSE
CurrencyUSD
ISINUS37733W2044
CUSIP37733W204
Income (Latest Year)
Revenue$31.95B
Gross Profit$23.18B
EBITDA$11.62B
Operating Income$7.01B
Net Income$5.59B
EPS$2.76
EPS Diluted$2.72
Shares Outstanding$2.03B
Balance Sheet (Latest Year)
Total Assets$61.01B
Current Assets$17.48B
Cash & ST Investments$3.4B
Total Liabilities$45.02B
Total Debt$17.69B
Net Debt$14.3B
Total Equity$15.93B
Debt / Equity1.11
Valuation Ratios
P/E Ratio21.4
P/S Ratio3.71
P/B Ratio7.45
EV/EBITDA (approx)10.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message